Real-world effectiveness of recombinant herpes Zoster vaccine: a retrospective, cohort study in Japan
Abstract Background In Japan, a two-dose, recombinant herpes zoster vaccine (RZV) has been available since 2020, but vaccination coverage is low because vaccination is voluntary. This study investigated the real-world effectiveness of the RZV for preventing herpes zoster (HZ) by using clinical datab...
Saved in:
| Main Authors: | Satoko Ohfuji, Nozomu Toyama, Kyoko Kondo, Hisao Muto, Wakaba Fukushima |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Infectious Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12879-025-11369-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Herpes Zoster Patient Pathway and Gaps in Current Vaccination Guidelines in Southeast Asia: Summary of a Zoster Experts’ Network Scientific Workshop
by: Gyneth Lourdes G. Bibera, et al.
Published: (2024-12-01) -
Unilateral Laterothoracic Exanthem in an Adult Following Recombinant Zoster Vaccination
by: Xinjin Liu, et al.
Published: (2025-07-01) -
Herpes zóster en un niño inmunocompetente
by: Paola Andrea Torres, et al.
Published: (2019-08-01) -
Vaccination in adults at-increased risk of herpes zoster in Canada: insights from a multidisciplinary panel consensus
by: Wayne Ghesquière, et al.
Published: (2025-12-01) -
Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complicationsResearch in context
by: Ana Strezova, et al.
Published: (2025-05-01)